Rex American [REX] vs Asp Isotopes [ASPI] Detailed Stock Comparison
Rex American
NYSE
Loading...
Asp Isotopes
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Rex American wins in 12 metrics, Asp Isotopes wins in 6 metrics, with 0 ties. Rex American appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Rex American | Asp Isotopes | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.55 | -13.92 | Asp Isotopes |
| Price-to-Book Ratio | 1.84 | 28.74 | Rex American |
| Debt-to-Equity Ratio | 3.90 | 359.18 | Rex American |
| PEG Ratio | -0.52 | -0.04 | Rex American |
| EV/EBITDA | 10.90 | -25.12 | Asp Isotopes |
| Profit Margin (TTM) | 7.91% | 38.60% | Asp Isotopes |
| Operating Margin (TTM) | 5.12% | -998.76% | Rex American |
| EBITDA Margin (TTM) | 5.12% | N/A | N/A |
| Return on Equity | 10.30% | -469.60% | Rex American |
| Return on Assets (TTM) | 5.36% | -21.64% | Rex American |
| Free Cash Flow (TTM) | $-7.13M | $-28.07M | Rex American |
| 1-Year Return | 38.98% | 225.19% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 1.55 | 173.53 | Rex American |
| Enterprise Value | $804.80M | $806.40M | Asp Isotopes |
| EV/Revenue Ratio | 1.24 | 176.01 | Rex American |
| Gross Profit Margin (TTM) | 9.03% | 47.74% | Asp Isotopes |
| Revenue per Share (TTM) | $38 | $0 | Rex American |
| Earnings per Share (Diluted) | $2.96 | $-1.40 | Rex American |
| Beta (Stock Volatility) | 0.66 | 3.38 | Rex American |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Rex American vs Asp Isotopes Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Rex American | -1.46% | -1.36% | 12.13% | 34.91% | 68.41% | 42.43% |
| Asp Isotopes | 1.39% | 6.95% | -21.77% | 4.90% | 113.38% | 77.53% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Rex American | 38.98% | 116.02% | 172.90% | 255.11% | 1,202.57% | 1,172.59% |
| Asp Isotopes | 225.19% | 213.57% | 213.57% | 213.57% | 213.57% | 213.57% |
News Based Sentiment: Rex American vs Asp Isotopes
Rex American
News based Sentiment: MIXED
The month presented a mixed bag for REX American Resources, with declining net income offset by strategic investments in carbon sequestration and ethanol expansion, alongside a shareholder-friendly stock split. While the earnings report was somewhat disappointing, the company's strong cash position and positive outlook for ethanol exports suggest potential for future growth.
Asp Isotopes
News based Sentiment: MIXED
September presented a mixed bag for ASPI, with operational advancements and strategic partnerships overshadowed by a significant earnings miss. While the company is making strides in expanding its production capabilities and entering new markets, profitability remains a key concern for investors. The continued institutional support and analyst upgrades suggest some confidence in the long-term potential, but the near-term outlook is uncertain.
Performance & Financial Health Analysis: Rex American vs Asp Isotopes
| Metric | REX | ASPI |
|---|---|---|
| Market Information | ||
| Market Cap | $1.01B | $806.08M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 121,116 | 5,023,930 |
| 90 Day Avg. Volume | 106,372 | 4,489,490 |
| Last Close | $60.83 | $8.77 |
| 52 Week Range | $33.45 - $64.95 | $2.50 - $11.68 |
| % from 52W High | -6.34% | -24.91% |
| All-Time High | $64.95 (Aug 28, 2025) | $11.26 (Aug 12, 2025) |
| % from All-Time High | -6.34% | -22.11% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.17% |
| Quarterly Earnings Growth | -0.43% | 0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.39% |
| Operating Margin (TTM) | 0.05% | -9.99% |
| Return on Equity (TTM) | 0.10% | -4.70% |
| Debt to Equity (MRQ) | 3.90 | 359.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $33.02 | $0.30 |
| Cash per Share (MRQ) | $18.78 | $0.74 |
| Operating Cash Flow (TTM) | $71.29M | $-19,671,420 |
| Levered Free Cash Flow (TTM) | $-25,351,500 | $-50,515,608 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Rex American vs Asp Isotopes
| Metric | REX | ASPI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.55 | -13.92 |
| Forward P/E | 26.80 | -57.67 |
| PEG Ratio | -0.52 | -0.04 |
| Price to Sales (TTM) | 1.55 | 173.53 |
| Price to Book (MRQ) | 1.84 | 28.74 |
| Market Capitalization | ||
| Market Capitalization | $1.01B | $806.08M |
| Enterprise Value | $804.80M | $806.40M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.24 | 176.01 |
| Enterprise to EBITDA | 10.90 | -25.12 |
| Risk & Other Metrics | ||
| Beta | 0.66 | 3.38 |
| Book Value per Share (MRQ) | $33.02 | $0.30 |
Financial Statements Comparison: Rex American vs Asp Isotopes
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | REX | ASPI |
|---|---|---|
| Revenue/Sales | $158.34M | $1.10M |
| Cost of Goods Sold | $144.00M | $774,765 |
| Gross Profit | $14.34M | $326,840 |
| Research & Development | N/A | $1.53M |
| Operating Income (EBIT) | $8.40M | $-7.95M |
| EBITDA | $13.42M | $-8.23M |
| Pre-Tax Income | $13.63M | $-8.53M |
| Income Tax | $2.95M | $-70,720 |
| Net Income (Profit) | $10.67M | $-8.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | REX | ASPI |
|---|---|---|
| Cash & Equivalents | $159.91M | $55.97M |
| Total Current Assets | $398.77M | $59.03M |
| Total Current Liabilities | $42.58M | $8.18M |
| Long-Term Debt | $19.04M | $36.96M |
| Total Shareholders Equity | $619.64M | $45.73M |
| Retained Earnings | $768.61M | $-64.62M |
| Property, Plant & Equipment | $0 | $1.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | REX | ASPI |
|---|---|---|
| Operating Cash Flow | $-2.75M | $-7.16M |
| Capital Expenditures | N/A | $-2.36M |
| Free Cash Flow | $-10.38M | $-5.53M |
| Debt Repayment | N/A | $-262,304 |
| Common Stock Repurchase | $-32.67M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | REX | ASPI |
|---|---|---|
| Shares Short | 413,340 | 15.45M |
| Short Ratio | 4.36 | 3.44 |
| Short % of Float | 0.04% | 0.20% |
| Average Daily Volume (10 Day) | 121,116 | 5,023,930 |
| Average Daily Volume (90 Day) | 106,372 | 4,489,490 |
| Shares Outstanding | 17.19M | 72.07M |
| Float Shares | 14.54M | 66.93M |
| % Held by Insiders | 0.14% | 0.22% |
| % Held by Institutions | 0.85% | 0.45% |
Dividend Analysis & Yield Comparison: Rex American vs Asp Isotopes
| Metric | REX | ASPI |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |